Alistair M. Chalk

Alistair M. Chalk

Auto-generated profile, based on publicly available information

Alistair M. Chalk

St Vincent’s Institute of Medical Research, Fitzroy, Australia

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2005 in Science
Verified
Journal Article
Closed access
PDF file
Piero CarninciPiero Carninci
Piero Carninci
TKT. Kasukawa
T. Kasukawa
SKS. Katayama
S. Katayama
JGJ. Gough
J. Gough
MFM. C. Frith
M. C. Frith
YHY. Hayashizaki
Y. Hayashizaki
This study describes comprehensive polling of transcription start and termination sites and analysis of previously unidentified full-length complementary DNAs derived from the mouse genome. We identify the 5′ and 3′ boundaries of 181,047 transcripts with extensive variation in transcripts arising from alternative promoter usage, splicing, and polyadenylation. There are 16,247 new mouse protein-coding transcripts, including 5154 encoding previously unidentified proteins. Genomic mapping of the transcriptome reveals transcriptional forests, with overlapping transcription on both strands, separated by deserts in which few transcripts are observed. The data provide a comprehensive platform for the comparative analysis of mammalian transcriptional regulation in differentiation and development.

2 September 2005 in Science
Verified
Journal Article
Closed access
PDF file
SKS. Katayama
S. Katayama
YTY. Tomaru
Y. Tomaru
TKT. Kasukawa
T. Kasukawa
KWK. Waki
K. Waki
MNM. Nakanishi
M. Nakanishi
CWC. Wahlestedt
C. Wahlestedt
Antisense transcription (transcription from the opposite strand to a protein-coding or sense strand) has been ascribed roles in gene regulation involving degradation of the corresponding sense transcripts (RNA interference), as well as gene silencing at the chromatin level. Global transcriptome analysis provides evidence that a large proportion of the genome can produce transcripts from both strands, and that antisense transcripts commonly link neighboring “genes” in complex loci into chains of linked transcriptional units. Expression profiling reveals frequent concordant regulation of sense/antisense pairs. We present experimental evidence that perturbation of an antisense RNA can alter the expression of sense messenger RNAs, suggesting that antisense transcription contributes to control of transcriptional outputs in mammals.

4 September 2015 in Science
Verified
Journal Article
Closed access
PDF file
BLBrian J. Liddicoat
Brian J. Liddicoat
RPRobert Piskol
Robert Piskol
ACAlistair M. Chalk
Alistair M. Chalk
GRGokul Ramaswami
Gokul Ramaswami
MHMiyoko Higuchi
Miyoko Higuchi
CWCarl R. Walkley
Carl R. Walkley
RNA editing helps identify cellular RNAs: Adenosine bases in messenger RNA (mRNAs) can be enzymatically modified and changed into inosine bases. This RNA “editing” is mediated by adenosine deaminase acting on RNA (ADAR) enzymes. Liddicoat et al. show that the in vivo targets of the principal editing enzyme, ADAR1, are long double-stranded RNA (dsRNA) structures in noncoding portions of cellular mRNAs. ADAR1-directed editing of these cellular targets is critical to avoid activation of an immune response to dsRNA in the cytoplasm, because dsRNA is also a marker of viral infection. Science , this issue p. 1115

28 October 2010 in Disease Models & Mechanisms
Verified
Journal Article
Open access
PDF file
NMNicholas Matigian
Nicholas Matigian
GAGreger Abrahamsen
Greger Abrahamsen
RSRatneswary Sutharsan
Ratneswary Sutharsan
ACAnthony L Cook
Anthony L Cook
AVAlejandra M. Vitale
Alejandra M. Vitale
AMAlan Mackay-Sim
Alan Mackay-Sim
SUMMARY: There is a pressing need for patient-derived cell models of brain diseases that are relevant and robust enough to produce the large quantities of cells required for molecular and functional analyses. We describe here a new cell model based on patient-derived cells from the human olfactory mucosa, the organ of smell, which regenerates throughout life from neural stem cells. Olfactory mucosa biopsies were obtained from healthy controls and patients with either schizophrenia, a neurodevelopmental psychiatric disorder, or Parkinson’s disease, a neurodegenerative disease. Biopsies were dissociated and grown as neurospheres in defined medium. Neurosphere-derived cell lines were grown in serum-containing medium as adherent monolayers and stored frozen. By comparing 42 patient and control cell lines we demonstrated significant disease-specific alterations in gene expression, protein expression and cell function, including dysregulated neurodevelopmental pathways in schizophrenia and dysregulated mitochondrial function, oxidative stress and xenobiotic metabolism in Parkinson’s disease. The study has identified new candidate genes and cell pathways for future investigation. Fibroblasts from schizophrenia patients did not show these differences. Olfactory neurosphere-derived cells have many advantages over embryonic stem cells and induced pluripotent stem cells as models for brain diseases. They do not require genetic reprogramming and they can be obtained from adults with complex genetic diseases. They will be useful for understanding disease aetiology, for diagnostics and for drug discovery.

18 February 2007 in Nature Methods
Verified
Journal Article
Closed access
PDF file
YMYasumasa Mitani
Yasumasa Mitani
ALAlexander Lezhava
Alexander Lezhava
YKYuki Kawai
Yuki Kawai
TKTakeshi Kikuchi
Takeshi Kikuchi
AOAtsuko Oguchi-Katayama
Atsuko Oguchi-Katayama
YHYoshihide Hayashizaki
Yoshihide Hayashizaki

11 December 2008 in Genome Research
Verified
Journal Article
Open access
PDF file
EVEivind Valen
Eivind Valen
GPGiovanni Pascarella
Giovanni Pascarella
ACAlistair Chalk
Alistair Chalk
NMNorihiro Maeda
Norihiro Maeda
MKMiki Kojima
Miki Kojima
Piero CarninciPiero Carninci
Piero Carninci
Finding and characterizing mRNAs, their transcription start sites (TSS), and their associated promoters is a major focus in post-genome biology. Mammalian cells have at least 5–10 magnitudes more TSS than previously believed, and deeper sequencing is necessary to detect all active promoters in a given tissue. Here, we present a new method for high-throughput sequencing of 5′ cDNA tags—DeepCAGE: merging the Cap Analysis of Gene Expression method with ultra-high-throughput sequence technology. We apply DeepCAGE to characterize 1.4 million sequenced TSS from mouse hippocampus and reveal a wealth of novel core promoters that are preferentially used in hippocampus: This is the most comprehensive promoter data set for any tissue to date. Using these data, we present evidence indicating a key role for theArnt2transcription factor in hippocampus gene regulation. DeepCAGE can also detect promoters used only in a small subset of cells within the complex tissue.